Didier Sandra, Vauthier Jean-Charles, Gambier Nicolas, Renaud Pierre, Chenuel Bruno, Poussel Mathias
a Department of General Practice , Maison de Santé des Trois Monts , Dommartin-les-Remiremont , France.
b Department of Clinical Pharmacology and Toxicology , CHRU Nancy , Nancy , France.
Res Sports Med. 2017 Apr-Jun;25(2):244-251. doi: 10.1080/15438627.2017.1282356. Epub 2017 Jan 23.
Endurance and ultra-endurance events have become increasingly popular. The aim of our study was to explore the use of medication among endurance runners participating in the 2014 Infernal Trail des Vosges. Among the 389 runners engaged, 297 (76.3%) completed a specific questionnaire dealing with substance use/misuse. Our results show a 27% (before the race) and 18% (during the race) prevalence of substance use. The two major classes of substances used were non-steroidal anti-inflammatory drugs (NSAIDs; 9.8%) and painkillers (6.7%), principally because of osteo-articular pain (29.6%) or to prevent pain (28.2%). A positive correlation was found between substance consumption before (past month) and during the race (overall medication: p < 0.0001; NSAIDs: p = 0.008). Our results could be explained by the specific characteristics of ultrarunners predominantly motivated by personal achievement and general health (recreational approach). However, education interventions should further be delivered regarding the risks of substance use in ultra-endurance events.
耐力和超耐力赛事越来越受欢迎。我们研究的目的是探讨参加2014年孚日地狱之路越野赛的耐力跑者的用药情况。在389名参赛跑者中，297名（76.3%）完成了一份关于药物使用/滥用情况的特定问卷。我们的研究结果显示，药物使用的患病率在赛前为27%，赛中为18%。使用的两大类药物是非甾体抗炎药（NSAIDs；9.8%）和止痛药（6.7%），主要原因是骨关节炎疼痛（29.6%）或预防疼痛（28.2%）。在赛前（过去一个月）和赛中（总体用药情况：p < 0.0001；NSAIDs：p = 0.008）的药物消费之间发现了正相关。我们的研究结果可以用超跑者的特定特征来解释，他们主要受个人成就和总体健康（休闲方式）的激励。然而，应进一步开展关于超耐力赛事中药物使用风险的教育干预。
